This site is intended for Healthcare Professionals only

GLP-1s

obesity-glp1-conceptual-arty-1

GLP-1s: Weight loss and beyond

Aside from their usefulness in managing type 2 diabetes and weight loss, where might GLP-1 drugs fit into the treatment landscape for a range of other health conditions? Rod Tucker reports

23 Feb 2026 , 1 Min Article

evidence

What happens when GLP-1 treatment stops?

GLP-1s have been hailed as a revolutionary medical breakthrough in the fight against obesity. But what happens when the drug stops? A recent analysis provides an interesting but somewhat disturbing finding. Rod Tucker takes a closer look…

20 Feb 2026 , 1 Min Article

semaglutide-summary

MHRA re-issues GLP-1 product information to strengthen pancreatitis warning

Watchdog updates patient information to highlight 'rare' risk of severe pancreatitis

03 Feb 2026 , 1 Min Article

wegovy-summary

‘Triple-strength’ Wegovy injection gets MHRA approval

Wegovy 7.2mg slated for 2026 UK launch, says manufacturer Novo Nordisk

14 Jan 2026 , 1 Min Article

Change privacy settings